Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 18 studies | 25% ± 9% | |
| endothelial cell | 14 studies | 28% ± 15% | |
| macrophage | 11 studies | 27% ± 10% | |
| astrocyte | 10 studies | 30% ± 15% | |
| microglial cell | 9 studies | 29% ± 12% | |
| pericyte | 8 studies | 25% ± 7% | |
| smooth muscle cell | 7 studies | 20% ± 4% | |
| adipocyte | 7 studies | 26% ± 6% | |
| epithelial cell | 6 studies | 32% ± 7% | |
| myeloid cell | 6 studies | 26% ± 16% | |
| platelet | 3 studies | 28% ± 3% | |
| ciliated cell | 3 studies | 19% ± 4% | |
| basal cell | 3 studies | 23% ± 8% | |
| cholangiocyte | 3 studies | 50% ± 23% | |
| hepatocyte | 3 studies | 47% ± 32% | |
| ependymal cell | 3 studies | 31% ± 12% | |
| kidney distal convoluted tubule epithelial cell | 3 studies | 21% ± 4% | |
| oligodendrocyte precursor cell | 3 studies | 31% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 8549.73 | 244 / 245 | 100% | 87.73 | 500 / 502 |
| breast | 100% | 14551.18 | 459 / 459 | 99% | 160.38 | 1105 / 1118 |
| skin | 100% | 16946.45 | 1809 / 1809 | 99% | 131.21 | 465 / 472 |
| esophagus | 100% | 9325.35 | 1445 / 1445 | 98% | 75.99 | 180 / 183 |
| lung | 100% | 9924.30 | 577 / 578 | 98% | 95.06 | 1136 / 1155 |
| intestine | 99% | 7612.68 | 955 / 966 | 99% | 74.07 | 520 / 527 |
| kidney | 100% | 9052.45 | 89 / 89 | 97% | 76.58 | 873 / 901 |
| liver | 98% | 5738.67 | 221 / 226 | 99% | 82.82 | 400 / 406 |
| uterus | 100% | 11701.88 | 170 / 170 | 95% | 84.78 | 438 / 459 |
| thymus | 99% | 7156.91 | 648 / 653 | 96% | 67.08 | 579 / 605 |
| bladder | 100% | 7654.10 | 21 / 21 | 93% | 73.98 | 470 / 504 |
| ovary | 87% | 4308.16 | 156 / 180 | 98% | 90.21 | 421 / 430 |
| adrenal gland | 98% | 5434.62 | 252 / 258 | 80% | 55.39 | 183 / 230 |
| stomach | 74% | 4384.53 | 267 / 359 | 98% | 65.88 | 280 / 286 |
| pancreas | 41% | 1432.10 | 135 / 328 | 99% | 163.43 | 176 / 178 |
| brain | 49% | 1639.37 | 1288 / 2642 | 85% | 42.54 | 598 / 705 |
| adipose | 100% | 18882.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 34515.67 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 77.84 | 80 / 80 |
| spleen | 99% | 6819.73 | 238 / 241 | 0% | 0 | 0 / 0 |
| heart | 98% | 8339.75 | 847 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 76.67 | 41 / 45 |
| muscle | 64% | 2555.35 | 517 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 17% | 4.68 | 5 / 29 |
| peripheral blood | 3% | 99.96 | 28 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0033627 | Biological process | cell adhesion mediated by integrin |
| GO_0007160 | Biological process | cell-matrix adhesion |
| GO_0035987 | Biological process | endodermal cell differentiation |
| GO_0046718 | Biological process | symbiont entry into host cell |
| GO_0007229 | Biological process | integrin-mediated signaling pathway |
| GO_0043149 | Biological process | stress fiber assembly |
| GO_0090136 | Biological process | epithelial cell-cell adhesion |
| GO_0098609 | Biological process | cell-cell adhesion |
| GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
| GO_0035313 | Biological process | wound healing, spreading of epidermal cells |
| GO_0016477 | Biological process | cell migration |
| GO_0043235 | Cellular component | receptor complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0008305 | Cellular component | integrin complex |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005925 | Cellular component | focal adhesion |
| GO_0009986 | Cellular component | cell surface |
| GO_0045335 | Cellular component | phagocytic vesicle |
| GO_0034684 | Cellular component | integrin alphav-beta5 complex |
| GO_0001618 | Molecular function | virus receptor activity |
| GO_0005178 | Molecular function | integrin binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ITGB5 |
| Protein name | Integrin beta-5 Integrin subunit beta 5 Integrin beta |
| Synonyms | |
| Description | FUNCTION: Integrin alpha-V/beta-5 (ITGAV:ITGB5) is a receptor for fibronectin. It recognizes the sequence R-G-D in its ligand.; FUNCTION: (Microbial infection) Integrin ITGAV:ITGB5 acts as a receptor for adenovirus type C. . |
| Accessions | ENST00000481591.5 ENST00000296181.9 H7C4W1 ENST00000608657.5 V9GZ57 ENST00000465464.5 ENST00000608107.1 V9GYZ1 ENST00000488466.5 V9GYD8 P18084 L7RT22 H7C5U2 ENST00000496703.1 H7C580 ENST00000483168.5 F8WBG2 |